Browse All

Current Filters

CLEAR FILTER x

TITLE

CD4 T Cell Responses to the Epstein-Barr Virus are Reduced by Disease-modifying Therapies in Patients with Multiple Sclerosis

Author:Drosu, Natalia   Bilodeau, Philippe-Antoine   Mahler, Joao Vitor   Anderson, Monique   Mikami, Takahisa   Bobrowski-Khoury, Natasha   Levy, Michael   

Session Name:P5: Multiple Sclerosis: Biomarkers and Immunology 1  

Topic:Multiple Sclerosis  

Program Number:P5.014  

Author Institution:Massachusetts General Hospital, Boston, MA  Massachusetts General Hospital, São Paulo, Brazil  Massachusetts General Hospital, Cambridge, MA  

NeofiLos –sNfL in Daily Clinical Routine

Author:Akgün, Katja   Katrin, Schuh   Schwab Sauerbeck, Inessa   Ziemssen, Tjalf   

Session Name:P5: Multiple Sclerosis: Biomarkers and Immunology 1  

Topic:Multiple Sclerosis  

Program Number:P5.015  

Author Institution:Center of Clinical Neuroscience, Dresden, Germany  Novartis Pharma GmbH, Nuernberg, Germany  

Focusing on Mithocondrial Dysfunction in Multiple Sclerosis: The Role of GDF-15 and FGF-21 as Prognostic Biomarkers

Author:Carlomagno, Vincenzo   Cicia, Alessandra   Bianco, Assunta   Lucchini, Matteo   Mirabella, Massimiliano   

Session Name:P5: Multiple Sclerosis: Biomarkers and Immunology 1  

Topic:Multiple Sclerosis  

Program Number:P5.016  

Author Institution:

Diagnostic Biomarkers Prior to Immunosuppressive Treatments: Multiple Sclerosis Compared to Control Non-autoimmune and Autoimmune Patient Groups

Author:Albritton, Jacob   Sarsour, Reem   Mahutga, Josh   Dong, Fanglong   Rosenthal, Johanna   

Session Name:P5: Multiple Sclerosis: Biomarkers and Immunology 1  

Topic:Multiple Sclerosis  

Program Number:P5.017  

Author Institution:Arrowhead Regional Medical Center, Rialto, CA  Arrowhead Regional Medical Center, Colton, CA